Clinical Trial Update: Neoadjuvant Nivolumab for Upper Tract Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating neoadjuvant nivolumab for upper urinary tract urothelial carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Urinary Tract Urothelial Carcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: YULISU | Conditions: Upper Urinary Tract Urothelial Carcinoma | Phase 2 | Status: UNKNOWN